Medicare Enrolled
Dr. Michael Waters, D.O.
Urology Physician · Fort Worth, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Waters from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Waters?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Waters
Dr. Michael Waters is an urology physician in Fort Worth, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Waters performed 34,311 Medicare services across 5,116 unique beneficiaries.
Between the years covered by Open Payments, Dr. Waters received a total of $26,819 from 66 pharmaceutical and/or device companies across 602 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Waters is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in TX
$26,819 industry payments
Medicare Practice Summary
Medicare Utilization ↗34,311
Medicare services
Top 3% in TX for urology physician
5,116
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,716 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
19,166 | $0 | $0 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
4,888 | $34 | $88 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
1,874 | $34 | $88 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,475 | $2 | $16 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,322 | $90 | $319 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,266 | $8 | $27 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
1,128 | $69 | $175 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
375 | $34 | $88 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
374 | $34 | $88 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
374 | $34 | $88 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
374 | $34 | $88 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
374 | $34 | $88 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
303 | $11 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
210 | $65 | $225 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
120 | $118 | $415 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
106 | $0 | $1 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
103 | $18 | $58 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
84 | $188 | $606 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
50 | $40 | $155 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
45 | $10 | $35 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
40 | $48 | $154 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
40 | $73 | $279 |
| Injection, garamycin, gentamicin, up to 80 mg | 26 | $2 | $7 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $38 | $141 |
| Simple change of bladder tube | 23 | $75 | $243 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
20 | $58 | $191 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
19 | $288 | $970 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
19 | $25 | $160 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
19 | $295 | $954 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
18 | $153 | $487 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves the electronic evaluation of an implanted neurostimulator generator. It includes complex programming of spinal cord or peripheral nerve stimulators. |
14 | $38 | $140 |
| Electronic analysis of implanted neurostimulator This procedure involves electronically analyzing an implanted neurostimulator generator and performing simple programming for spinal cord or peripheral nerve stimulation. |
13 | $37 | $119 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
12 | $611 | $1,975 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
12 | $19 | $72 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$26,819
Total received (2018-2024)
Avg $3,831/year across 7 years
Top 10% in TX for urology physician
66
Companies
602
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,048 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$771 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,771
2023
$4,346
2022
$6,211
2021
$4,270
2020
$2,200
2019
$3,521
2018
$2,499
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$2,995
AngioDynamics, Inc.
$2,541
NeoTract Inc.
$2,065
COLOPLAST CORP
$1,918
Teleflex LLC
$1,649
Medtronic USA, Inc.
$1,555
Coloplast Corp
$1,399
Janssen Biotech, Inc.
$1,236
Axonics, Inc.
$1,212
Endo Pharmaceuticals Inc.
$904
Astellas Pharma US Inc
$761
Valencia Technologies Corporation
$754
Uromedica, Incorporated
$613
Axonics Modulation Technologies, Inc.
$494
Dendreon Pharmaceuticals LLC
$421
Rochester Medical Corporation
$418
Sumitomo Pharma America, Inc.
$406
Allergan Inc.
$392
AbbVie Inc.
$382
Innovation Technologies Inc
$254
Boston Scientific Corporation
$252
Olympus America Inc.
$239
BOSTON SCIENTIFIC CORPORATION
$227
Janssen Scientific Affairs, LLC
$202
Antares Pharma, Inc.
$197
Agiliti Surgical, Inc.
$196
180 Medical, Inc.
$191
PFIZER INC.
$174
PROCEPT BioRobotics Corporation
$164
UROVANT SCIENCES INC
$161
Laborie Medical Technologies Corp.
$157
Blue Earth Diagnostics Limited
$146
Olympus Corporation of the Americas
$142
ABBVIE INC.
$140
Bard Access Systems, Inc.
$136
Johnson & Johnson Health Care Systems Inc.
$129
Clarus Therapeutics Inc.
$125
Allergan, Inc.
$121
Myovant Sciences Inc.
$115
BK Medical Holding Company Inc.
$101
Agiliti Health, Inc.
$97
Endo USA, Inc.
$95
ACCORD HEALTHCARE, INC.
$87
TOLMAR Pharmaceuticals, Inc.
$83
AMAG Pharmaceuticals, Inc.
$78
Mission Pharmacal Company
$74
UROGEN PHARMA, INC.
$66
Tolmar, Inc.
$62
Supernus Pharmaceuticals, Inc.
$42
Ambu Inc.
$42
UroGen Pharma, Inc.
$40
Travere Therapeutics, Inc.
$40
Myriad Genetic Laboratories, Inc.
$35
PROGENICS PHARMACEUTICALS, INC.
$34
Verity Pharmaceuticals Inc.
$30
Accord Healthcare, Inc.
$30
HealthTronics Mobile Solutions, LLC
$29
Progenics Pharmaceuticals, Inc.
$29
BLUEWIND MEDICAL
$27
Bayer Healthcare Pharmaceuticals Inc.
$20
Hollister Incorporated
$19
AbbVie, Inc.
$18
Ferring Pharmaceuticals Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Aytu BioScience, Inc
$14
Avadel Specialty Pharmaceuticals, LLC
$13
Top 3 companies account for 28.3% of total payments
Associated products mentioned in payments ›
ADVANTAGE · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AVYCAZ · Altis · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bulkamid · CAMCEVI · CURE CATHETER · Coloplast TFL Drive · Dormia · ELIGARD · ENDOUROLOGY · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL - BPH · GENERAL - THERAPIES · GENERAL BPH · GENTLECATH · General - Kidney Stone Disease · General - Therapies · INTERSTIM · INTRAROSA · IRRISEPT · ImaJin · JATENZO · JELMYTO · LUPRON DEPOT · LithoVue · MAGIC3 · MYRBETRIQ · Mobile Cryoblation Services · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · Olympus Cysto-Resection · Onli · Optilume BPH Drug Coated Balloon Catheter · PENILE & TESTICULAR RECONSTRUCTN · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · ProACT · Prolaris · RETRACE · REZUM · ReTrace · Rezum Generator · SOLYX · STELARA · Sonablate · SpaceOAR VUE System - 10mL · SpeediCath · TITAN · TOVIAZ · Thiola · Titan · Torosa · Trelstar · URIBEL TABS · UROLIFT · Uribel · UroLift · UroLift System · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED · bk3000 · bk3500 & bk5000 Ultrasound System · eCoin Device Kit · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for urology physician in TX.
Equivalent to $78 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
85
Per 100K population
4.0
County median income
$81,905
Nearest hospital
TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHWEST F
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Waters is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with low-engagement industry engagement in the top 10% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Waters experienced with testosterone injection?
Based on Medicare claims data, Dr. Waters performed 19,166 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Waters receive payments from pharmaceutical companies?
Yes. Dr. Waters received a total of $26,819 from 66 companies across 602 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Waters's costs compare to other urology physicians in Fort Worth?
Dr. Waters's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Waters) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fort Worth
Browse urology physicians in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
AngioDynamics, Inc. Payments to Doctors
See all physicians who received payments from AngioDynamics, Inc.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology